Analysts expect In8Bio, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 156,487.82 | 241,400.75 | 3.59 M | 4.06 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 144,723.12 | 222,034.71 | 3.10 M | 3.75 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 150,605.47 | 231,717.73 | 3.35 M | 3.90 M |
Analysts expect In8Bio, Inc. to report earnings per share of -0.36 for Q3 26, against a range of -0.37 to -0.35. The most recent reported quarter, Q2 26, came in at -0.25, a 21.9% beat against the -0.32 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -4.50 | -2.40 | -2.10 | -1.24 | -0.85 | -0.45 | -0.26 | -0.25 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -4.82 | -1.88 | -1.99 | -1.57 | -1.06 | -0.60 | -0.53 | -0.29 | -0.35 | -0.32 | -0.29 | -0.34 | 0.19 | 0.47 | -0.39 | -0.44 | ||||||||||
| Low Estimate | -5.68 | -2.24 | -2.21 | -1.77 | -1.20 | -0.72 | -0.63 | -0.35 | -0.37 | -0.34 | -0.33 | -0.38 | 0.17 | 0.39 | -0.43 | -0.52 | ||||||||||
| Consensus Estimate | -5.25 | -2.06 | -2.10 | -1.67 | -1.13 | -0.66 | -0.58 | -0.32 | -0.36 | -0.33 | -0.31 | -0.36 | 0.18 | 0.43 | -0.41 | -0.48 |
Pull Wall Street consensus for In8Bio, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=INAB&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "INAB", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=INAB&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();